EspeRare is participating in the 8th iFeTIS Annual Meeting, being represented by Agnes Jaulent, PhD, and Sebastien Mazzuri, MD. The event taking place in the USA on November 1-2, 2024, is hosted by the Wake Forest Institute for Regenerative Medicine.
Agnes will present insights on the groundbreaking prenatal therapy for XLHED, while Sebastien will engage in dynamic discussions around the innovative advancements in prenatal therapies and the future of fetal interventions.
The iFeTIS meeting gathers international experts to share their knowledge, scientific outcomes, and clinical progress in the areas of prenatal treatments, fetal interventions, diagnostics, and clinical trials. The event will also address the ethical considerations and regulatory perspectives on fetal medicine, ensuring that scientific progress safeguards patients’ rights and well being.
EspeRare is inspired by the opportunity to exchange insights with world-leading experts dedicated to enhancing fetal health and care, and actively contribute to the development of a “roadmap forward” for this exciting field, bringing hope and innovative solutions in an ethical and responsible way.
For more information on the meeting please visit the following link: https://www.fetaltherapies.org/annual-meeting
